Do I need an in-person exam for Strattera in California?

Can You Get Non-Stimulant ADHD Medication Through Telehealth?

Yes, you can get non-stimulant ADHD medications like Strattera (atomoxetine) prescribed through telehealth in all 50 states. Unlike stimulant medications (Adderall, Ritalin, Vyvanse), non-stimulants aren’t controlled substances, which means they’re not subject to the strict DEA regulations that sometimes limit telehealth prescribing.

This comprehensive guide explains exactly how telehealth ADHD treatment works for non-stimulant medications, the current regulations as of December 2025, and what you need to know before seeking treatment online.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

Why Non-Stimulant ADHD Medications Are Easier to Get via Telehealth

Non-stimulant medications like Strattera have a significant advantage in telehealth: they aren’t regulated as controlled substances. This distinction makes a crucial difference:

• No DEA restrictions: The Ryan Haight Act (which can limit controlled substance prescribing via telehealth) doesn’t apply to non-stimulants
• Fewer state restrictions: Most state laws limiting telehealth prescribing target controlled substances only
• Longer prescriptions allowed: Can often be prescribed for 90 days with multiple refills (unlike stimulants’ 30-day limit)
• Lower risk profile: No potential for abuse or dependence, reducing regulatory scrutiny

For many patients who either can’t tolerate stimulants or prefer a non-controlled medication option, this makes telehealth an ideal way to access treatment.

Current Telehealth Regulations for ADHD Medications (Dec 2025)

Federal Regulations: Non-Stimulants vs. Stimulants

Key point: While stimulant prescribing via telehealth remains in a state of regulatory flux (the current DEA waiver expires December 31, 2025), non-stimulant medications have always been and remain fully authorized for telehealth prescribing under federal law.

State-by-State Rules for Non-Stimulant ADHD Medications

Most states allow telehealth prescribing of non-stimulant ADHD medications without special restrictions. Here’s a breakdown of the current regulations in key states:

California

• ✅ Telehealth allowed: Yes, fully permitted for ADHD treatment
• ❌ In-person exam requirement: None for non-stimulants
• 👨‍⚕️ Provider types: MDs, DOs, NPs (independent after experience requirements), and PAs can all prescribe

New York

• ✅ Telehealth allowed: Yes, with no special restrictions for non-stimulants
• ❌ In-person exam requirement: None (NY’s 2025 in-person rule only applies to controlled substances)
• 👨‍⚕️ Provider types: MDs, DOs, and NPs with 3,600+ hours experience can prescribe independently; PAs under collaboration

Florida

• ✅ Telehealth allowed: Yes, explicitly permitted by state law
• ❌ In-person exam requirement: None for non-controlled medications
• 👨‍⚕️ Provider types: MDs, DOs, and NPs/PAs under collaborative practice can prescribe

Texas

• ✅ Telehealth allowed: Yes, mental health telehealth is well-established
• ❌ In-person exam requirement: None for non-stimulants
• 👨‍⚕️ Provider types: MDs, DOs, and NPs/PAs under physician delegation can prescribe non-stimulants

Alabama

• ✅ Telehealth allowed: Yes, but with some unique requirements
• 🟡 In-person exam requirement: For ongoing treatment, patients need an in-person visit within 12 months (mental health services are exempt from this rule)
• 👨‍⚕️ Provider types: MDs, DOs, and NPs/PAs with collaborative agreements can prescribe

New Hampshire

• ✅ Telehealth allowed: Yes, recently expanded with SB 252 (2025)
• 🟡 In-person exam requirement: Annual evaluation required (can be via telehealth)
• 👨‍⚕️ Provider types: MDs, DOs, and NPs (independent practice) can prescribe; PAs under supervision

Georgia

• ✅ Telehealth allowed: Yes, no special prohibitions exist
• ❌ In-person exam requirement: None for non-stimulants
• 👨‍⚕️ Provider types: MDs, DOs, and NPs/PAs under collaborative practice can prescribe non-stimulants

Strattera (Atomoxetine): The Leading Non-Stimulant ADHD Option

Strattera stands as the most commonly prescribed non-stimulant ADHD medication. Here’s what makes it unique:

Unlike stimulants which work immediately, Strattera builds up in your system over several weeks. This means it doesn’t provide the immediate relief that stimulants do, but it also avoids the ups and downs many experience with stimulant medications. It’s particularly well-suited for:

• Patients with substance abuse concerns
• Those who experience significant side effects from stimulants
• People who need 24-hour symptom control (no ‘wearing off’ in evenings)
• Patients with comorbid anxiety who find stimulants too activating

The Telehealth ADHD Assessment Process

When seeking non-stimulant ADHD treatment through telehealth, you can expect a thorough evaluation process from any reputable provider:

1. Pre-appointment screening: Questionnaires about your symptoms, medical history, and past treatments
2. Video consultation: A comprehensive assessment with a licensed provider (typically 45-60 minutes)
3. Diagnostic evaluation: Using standardized DSM-5 criteria to confirm ADHD diagnosis
4. Medical history review: Checking for any conditions that might affect treatment
5. Treatment planning: Discussion of medication options, including non-stimulants
6. Prescription: If appropriate, an electronic prescription sent to your pharmacy
7. Follow-up care: Regular check-ins to monitor progress and adjust treatment

At Klarity Health, our board-certified providers conduct thorough evaluations for all ADHD patients. We offer both stimulant and non-stimulant treatment options based on your individual needs, preferences, and medical history.

Who Can Prescribe Non-Stimulant ADHD Medications via Telehealth?

The following providers can prescribe non-stimulant ADHD medications through telehealth in most states:

• Physicians (MD/DO): In all 50 states
• Nurse Practitioners (NPs): In all states, though some require physician collaboration
• Physician Assistants (PAs): In all states, typically under physician supervision
• Psychiatrists: Specialists in mental health who can prescribe in all states

For non-stimulants specifically, there are fewer restrictions on which providers can prescribe compare

Source:

• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20Drug%20Enforcement%20Administration%20,Federal%20Register%20on%20Friday%20night
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=visit,examination%20through%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.fiercehealthcare.com/regulatory/dea-finalizes-one-year-extension-controlled-substance-prescribing-telehealth-punts-final#:~:text=The%20%E2%80%9CThird%20Temporary%20Extension%20of,14
• https://www.medicalnewstoday.com/articles/drugs-is-strattera-a-controlled-substance#:~:text=Strattera%20,such%20as%20mental%20health%20issues
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=The%20,False%20Hope
• https://www.techtarget.com/virtualhealthcare/news/366616019/Telehealth-prescribing-flexibility-extended-through-2025#:~:text=Image%20filo%2FDigitalVision%20Vectors%20via%20G,The
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Extend%20natlawreview,before%20issuing%20a%20dangerous%20drug
• https://www.rxagent.co/blog/telehealth-compliance-trap#:~:text=,specifically%20for%20chronic%20pain%20treatment